Top Markets
#1 ADO Protocol ADO Protocol +329.10%
#2 GoPlus Security GoPlus Security +53.44%
#3 Nockchain Nockchain +43.26%
#4 Starpower Starpower +34.71%
#5 Tutorial Tutorial +34.36%
#6 The Black Bull The Black Bull +33.14%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +32.41%
#8 GAIB AID GAIB AID +24.67%
#9 Verus Coin Verus Coin +20.40%
#10 Fake World Assets Fake World Assets +18.95%
Coin of the day
ADO Protocol ADO Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Kedudukan dalam Saham #32812
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Harga Saham
$2.22
Modal Pasaran
$9.03M
Perubahan (1 hari)
-3.13%
Perubahan (1 tahun)
-21.92%
Negara
JP
Perdagangan PhoenixBio Co., Ltd. (6190)

Kategori

Healthcare
Hasil untuk PhoenixBio Co., Ltd. (6190)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada PhoenixBio Co., Ltd., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi PhoenixBio Co., Ltd. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE